Asset Discovery Agent

Discover overlooked drug assets with intelligent search

8 Geographies•28 Therapeutic Areas•30+ Modalities

Search Filters

Geographic Area

Discovery Year Range

20152024

Development Stage

Preclinical

Pre-IND

IND Filed

IND Approved

Entering Phase 1

Entering Phase 2

Shelved - Biotech

Shelved - Big Pharma

Therapeutic Areas

Oncology

Neurology

Cardiology

Immunology

Rare Disease

Infectious Disease

Metabolic Disease

Dermatology

Ophthalmology

Respiratory

Gastroenterology

Endocrinology

Nephrology

Hematology

Rheumatology

Psychiatry

Urology

Gynecology

Pediatrics

Geriatrics

Pain Management

Anesthesiology

Emergency Medicine

Critical Care

Transplantation

Regenerative Medicine

Precision Medicine

Digital Therapeutics

Drug Modalities

Small Molecule

ADC

Radiopharma

Biologics

RNA Therapy

Cell Therapy

Gene Therapy

Monoclonal Antibodies

Bispecific Antibodies

Peptides

Proteins

Vaccines

Oligonucleotides

Aptamers

Nanoparticles

Liposomes

Exosomes

Stem Cell Therapy

CAR-T Therapy

TCR Therapy

NK Cell Therapy

Oncolytic Viruses

Bacteriophages

Medical Devices

Digital Therapeutics

Combination Therapy

Prodrugs

Biosimilars

Immunoconjugates

Radioimmunoconjugates

Ready to Discover Assets

Use the search filters to explore our database of overlooked drug assets.

8

Geographies

28

Therapeutic Areas

30+

Modalities